Voluntary announcement - CU-40102 (topical finasteride spray) obtained marketing approval by the macao pharmaceutical administration bureau
Filed with HKEX · Stock code 2487 · · 2 pages · English
(Incorporated in the Cayman Islands with limited liability) (Stock Code: 2487) VOLUNTARY ANNOUNCEMENT CU-40102 (TOPICAL FINASTERIDE SPRAY) OBTAINED MARKETING APPROVAL BY THE MACAO PHARMACEUTICAL ADMINISTRATION BUREAU This announcement is made by Cutia Therapeutics (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders and potential investors of
Earlier from Cutia Therapeutics
Later from Cutia Therapeutics
- 2026 Interim Report
- Change of executive director
- List of directors and their roles and functions
- Voluntary announcement - share repurchase program under the share repurchase mandate
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Cutia Therapeutics into a list and get an email when it puts out news.
Follow Cutia Therapeutics